Skip to content

Ischemic Preconditioning in Osteoarthritis and Back Pain

Ischemic Preconditioning in Osteoarthritis and Back Pain

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07003113
Enrollment
24
Registered
2025-06-04
Start date
2025-09-12
Completion date
2026-12-31
Last updated
2025-11-17

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Knee Osteoarthritis, Low Back Pain

Keywords

ischemic preconditioning, restricted blood flow, knee pain, back pain

Brief summary

We are examining the use of restricted blood flow, through full occlusion, on a single thigh for 50 minutes (5 minutes on, 5 minutes off), completed every other day for 2 weeks to improve function in individuals with knee osteoarthritis and low back pain.

Interventions

DEVICEIschemic Preconditioning

The intervention arm will include full blood flow occlusion in one thigh for 5 minutes followed by 5 minutes of reperfusion for a cycle of 50 minutes.

DEVICESham Intervention

This intervention includes 25mmHg of pressure, which is not sufficient for blodo flow occlusion.

Sponsors

National Institute on Disability, Independent Living, and Rehabilitation Research
CollaboratorFED
University of Illinois at Chicago
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
50 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Reported Knee Pain using ACR Criteria * Reported Back Pain using ODI Criteria \> 12 * Ability to walk for at least 3 minutes without the use of aids * Ability to provide written informed consent

Exclusion criteria

* Younger than 50 years old * History of Knee or Hip Replacements * History of steroid injection within the previous 6 months * Presence of neuromuscular joint condition that affects lower extremity function * History of blood clots in the leg or any condition in which compression of the thigh is contraindicated * History of heart failure or thrombosis * Allergic to ultrasound gel * History of spine surgery * Non-English speaker * Currently pregnant or intends to become pregnant during the study

Design outcomes

Primary

MeasureTime frameDescription
Preferred walking speedAt baseline (from enrollment) until end of intervention (3 weeks).Changes in preferred walking speed (m/s) from intervention
Muscle strengthFrom baseline (enrollment) until end of intervention (3 weeks)Change in quadriceps, hamstring, and hip strength
Patient Reported OutcomesAt baseline (enrollment) through the intervention (3 weeks)Change in subjective function and reporting based on questionnaires
Gait KinematicsAt baseline (from enrollment) until end of intervention (3 weeks).Changes in gait kinematics (in degrees) from intervention
Gait Kinetics/MomentsAt baseline (from enrollment) until end of intervention (3 weeks).Changes in gait kinetics (joint moments) (in N/m) from intervention

Secondary

MeasureTime frameDescription
Cartilage HealthFrom baseline (enrollment) until completion of intervention (3 weeks)Change in knee cartilage thickness using ultrasound methods

Countries

United States

Contacts

Primary ContactShraddha Sudhir
ssudhi5@uic.edu312-413-5118

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026